News and views, Straight from the Doc

Visit Straight From the Doc

AlloMap : Novel Non-invasive Test For Managing Heart Transplant Patients

Posted on August 28, 2008

Photo courtesy of iStockphoto, Image# 1937886AlloMap - developed by XDx Inc. - is a non-invasive test utilizing molecular expression techniques that will help doctors in managing heart transplant patients after surgery to monitor organ rejection.The FDA has cleared AlloMap Molecular Expression Testing - making XDx Inc. the first U.S. molecular diagnostics company to obtain FDA clearance of an In Vitro Diagnostic Multivariate Index Assay (IVDMIA) for use in transplant management.AlloMap Testing assays the RNA levels of 11 rejection biomarker genes and nine control genes. AlloMap Testing was...

Original article link


children , lung , protein